PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $11,188,000 | -48.3% | 244,008 | -33.3% | 0.41% | -49.6% |
| Q2 2018 | $21,636,000 | -14.5% | 365,787 | -1.6% | 0.82% | -19.5% |
| Q1 2018 | $25,304,000 | -36.4% | 371,840 | -7.7% | 1.01% | -33.9% |
| Q4 2017 | $39,804,000 | -10.2% | 402,668 | +8.8% | 1.53% | -15.0% |
| Q3 2017 | $44,312,000 | +59.6% | 370,035 | +16.5% | 1.80% | +55.4% |
| Q2 2017 | $27,765,000 | +96.8% | 317,680 | -16.2% | 1.16% | +100.3% |
| Q1 2017 | $14,110,000 | +124.1% | 379,289 | +1102.0% | 0.58% | +83.2% |
| Q1 2015 | $6,297,000 | -34.4% | 31,556 | -37.8% | 0.32% | -37.9% |
| Q4 2014 | $9,600,000 | +36.0% | 50,721 | +71.5% | 0.51% | +21.5% |
| Q3 2014 | $7,057,000 | – | 29,580 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |